NTBL: Notable Labs Inc. Company Cash Volume

Symbol and logo of brand Notable Labs, Ltd. (NTBL)

Notable Labs, Ltd. (NTBL) is developing AI systems for therapy selection, leveraging B2B subscriptions and an asset-light structure. The cash position history demonstrates financial stability, where the parameter value equals 0.00. The company's liquidity is independent of global GDP cycles, while its pricing policy adapts to medical center requirements to accelerate the commercial validation of tests.

Notable Labs Inc. - NTBL Company Cash Balance (period 02/21/2024 - 11/02/2024)

Analytical breakdowns for Notable Labs, Ltd.

- stock value and consensus price forecast:
General company analysis:NTBL notablelabs.com
Brand item of notablelabs.com

Notable Labs, Ltd. (NTBL) is actively developing precision oncology technologies to capture market share. The dynamics of cash reserves reflect the daily balance of liquidity inflows and outflows. This metric allows for an assessment of the company's ability to fund R&D without waiting for quarterly reports. Amid fierce competition with tech behemoths, a sufficient capital cushion is critical for scaling AI algorithms. Stable cash balances guarantee operational resilience and support the share price.

Main competitors

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|PPBT: Company Cash Volume|Company Cash on Hand American Oncology Network Inc|BGNE (beigene.com) - Company Cash Volume|Company Cash and Cash Equivalents CKPT (Checkpoint Therapeutics)|Company Cash on Hand ELEV (Elevation Oncology Inc.)|iCAD - Company Cash and Cash Equivalents|Ikena Oncology Inc. - Company Cash on Hand|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds